keyword
https://read.qxmd.com/read/38702983/what-factors-influence-the-uptake-of-bowel-breast-and-cervical-cancer-screening-an-overview-of-international-research
#1
JOURNAL ARTICLE
Sarah R Prowse, Miriam Brazzelli, Shaun Treweek
BACKGROUND: For cancer screening programmes to be effective in early detection it is important that those invited can access screening services and understand the benefits of participation. A better understanding of the factors that matter to potential participants of cancer screening programmes can assist in developing strategies to increase current uptake. METHODS: We conducted an overview of systematic reviews to answer the question: What factors influence the uptake of cancer screening services (breast, bowel and cervical) in high-income countries? A thematic approach supported by tabular summaries and qualitative heat maps was used to categorize factors, described as 'barriers' or 'facilitators'...
May 3, 2024: European Journal of Public Health
https://read.qxmd.com/read/38702065/us-expert-panel-says-breast-cancer-screening-should-begin-at-40
#2
JOURNAL ARTICLE
Janice Hopkins Tanne
No abstract text is available yet for this article.
May 3, 2024: BMJ: British Medical Journal
https://read.qxmd.com/read/38701411/ai-identifies-potent-inducers-of-breast-cancer-stem-cell-differentiation-based-on-adversarial-learning-from-gene-expression-data
#3
JOURNAL ARTICLE
Zhongxiao Li, Antonella Napolitano, Monica Fedele, Xin Gao, Francesco Napolitano
Cancer stem cells (CSCs) are a subpopulation of cancer cells within tumors that exhibit stem-like properties and represent a potentially effective therapeutic target toward long-term remission by means of differentiation induction. By leveraging an artificial intelligence approach solely based on transcriptomics data, this study scored a large library of small molecules based on their predicted ability to induce differentiation in stem-like cells. In particular, a deep neural network model was trained using publicly available single-cell RNA-Seq data obtained from untreated human-induced pluripotent stem cells at various differentiation stages and subsequently utilized to screen drug-induced gene expression profiles from the Library of Integrated Network-based Cellular Signatures (LINCS) database...
March 27, 2024: Briefings in Bioinformatics
https://read.qxmd.com/read/38700244/the-activity-of-pyrazolo-4-3-e-1-2-4-triazine-and-pyrazolo-4-3-e-tetrazolo-1-5-b-1-2-4-triazine-sulphonamide-derivatives-in-monolayer-and-spheroid-breast-cancer-cell-cultures
#4
JOURNAL ARTICLE
Anna Szymanowska, Dominika Radomska, Robert Czarnomysy, Mariusz Mojzych, Katarzyna Kotwica-Mojzych, Krzysztof Bielawski, Anna Bielawska
In the last decade, an increasing interest in compounds containing pyrazolo[4,3- e ][1,2,4]triazine moiety is observed. Therefore, the aim of the research was to synthesise a novel sulphonyl pyrazolo[4,3- e ][1,2,4]triazines ( 2a , 2b ) and pyrazolo[4,3- e ]tetrazolo[1,5- b ][1,2,4]triazine sulphonamide derivatives ( 3a , 3b ) to assess their anticancer activity. The MTT assay showed that 2a , 2b , 3a , 3b have stronger cytotoxic activity than cisplatin in both breast cancer cells (MCF-7 and MDA-MB-231) and exhibited weaker effect on normal breast cells (MCF-10A)...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38699696/clinical-significance-of-serum-synaptophysin-like-1-protein-levels-in-breast-cancer
#5
JOURNAL ARTICLE
Yagmur Ozge Turac Kosem, Hafize Uzun, Mehmet Velidedeoglu, Pınar Kocael, Seyma Dumur, Osman Simsek
BACKGROUND: Mammography, used for breast cancer (BC) screening, has limitations such as decreased sensitivity in dense breasts. Currently used tumor markers are insufficient in diagnosing breast cancer. In this study, we aimed to investigate the relationship between serum levels of synaptophysin-like protein 1 (SYPL1) and BC and compare SYPL1 with other blood tumor markers. METHODS: The study group consisted of 80 female patients with a histopathological diagnosis of invasive BC who received no radiotherapy/chemotherapy...
April 23, 2024: Journal of Medical Biochemistry
https://read.qxmd.com/read/38698754/computational-screening-of-some-phytochemicals-to-identify-best-modulators-for-ligand-binding-domain-of-estrogen-receptor-alpha
#6
JOURNAL ARTICLE
Veerachamy Alagarsamy, P Shyam Sundar, Viswas Raja Solomon, Sankaranarayanan Murugesan, Mohammed Muzaffar-Ur-Rehman, Vishaka Sumant Kulkarni, Mohaideen Thasthagir Sulthana, Bandi Narendhar, Govindraj Sabarees
OBJECTIVE: The peculiar aim of this study is to discover and identify the most effective and potential inhibitors against the most influential target ERα receptor by in silico studies of 45 phytochemicals from six diverse ayurvedic medicinal plants. METHODS: The molecular docking investigation was carried out by the genetic algorithm program of AutoDock Vina. The molecular dynamic (MD) simulation investigations were conducted using the Desmond tool of Schrödinger molecular modelling...
May 2, 2024: Current Pharmaceutical Design
https://read.qxmd.com/read/38698585/feasibility-study-comparing-synthesized-mammography-with-digital-breast-tomosynthesis-and-digital-mammography-for-simulated-first-round-screening-in-a-single-breastscreen-nsw-centre
#7
JOURNAL ARTICLE
Vikrant Dhurandhar, Nalini Bhola, Mico Chan, Sarah Choi, Tzu-Yun Chung, Bruno Giuffre, Nigel Hunter, Katelyn Lee, Merran McKessar, Ranjani Reddy, Marian Roberts, Christine Shearman, Meredith Kay, Ken Bruderlin, Niko Winarta, Jennifer Noakes
INTRODUCTION: While digital breast tomosynthesis (DBT) has proven to enhance cancer detection and reduce recall rates (RR), its integration into BreastScreen Australia for screening has been limited, in part due to perceived cost implications. This study aims to assess the cost effectiveness of digital mammography (DM) compared with synthesized mammography and DBT (SM + DBT) in a first round screening context for short-term outcomes. METHODS: Clients recalled for nonspecific density (NSD) as a single lesion by both readers at the Northern Sydney Central Coast BreastScreen service in 2019 were included...
May 2, 2024: Journal of Medical Imaging and Radiation Oncology
https://read.qxmd.com/read/38698386/a-stakeholder-analysis-to-prepare-for-real-world-evaluation-of-integrating-artificial-intelligent-algorithms-into-breast-screening-prep-air-study-a-qualitative-study-using-the-who-guide
#8
JOURNAL ARTICLE
Rumana Newlands, Hanne Bruhn, Magdalena Rzewuska Díaz, Gerald Lip, Lesley A Anderson, Craig Ramsay
BACKGROUND: The national breast screening programme in the United Kingdom is under pressure due to workforce shortages and having been paused during the COVID-19 pandemic. Artificial intelligence has the potential to transform how healthcare is delivered by improving care processes and patient outcomes. Research on the clinical and organisational benefits of artificial intelligence is still at an early stage, and numerous concerns have been raised around its implications, including patient safety, acceptance, and accountability for decisions...
May 2, 2024: BMC Health Services Research
https://read.qxmd.com/read/38697846/data-resource-profile-the-cancer-public-library-database-in-south-korea
#9
JOURNAL ARTICLE
Dong-Woo Choi, Minyeong Guk, Hyeri Kim, Kwang Sun Ryu, Hyun-Joo Kong, Hyo Soung Cha, Hyun-Jin Kim, Heejung Chae, Young Sang Jeon, Hwanhee Kim, JipMin Jung, Jeong-Soo Im, Kui Son Choi
This paper provides a comprehensive overview of the Cancer Public Library Database (CPLD), established under the Korean Clinical Data Utilization for Research Excellence project (K-CURE). The CPLD links data from four major population-based public sources: the Korea National Cancer Incidence Database in the Korea Central Cancer Registry, cause-of-death data in Statistics Korea, the National Health Information Database in the National Health Insurance Service, and the National Health Insurance Research Database in the Health Insurance Review & Assessment Service...
April 30, 2024: Cancer Research and Treatment: Official Journal of Korean Cancer Association
https://read.qxmd.com/read/38697004/breast-imaging-reporting-and-data-system-for-sonography-positive-and-negative-predictive-values-of-sonographic-features-in-kumasi-ghana
#10
JOURNAL ARTICLE
Augustina Badu-Peprah, Obed Kojo Otoo, Mansa Amamoo, Frank Quarshie, Benjamin Adomako
BACKGROUND: Breast cancer is the most common female cancer globally. The method of choice for screening and diagnosing breast cancer is mammography, which is not widely available in Ghana as compared to ultrasonography. This study aimed to evaluate the sonographic features of solid breast lesions using the new sonographic Breast Imaging- Reporting and Data System (BI-RADS-US) lexicon for malignancy with histopathology as the gold standard. METHODS: This was a prospective quantitative study that sonographically scanned female patients with breast masses and consecutively selected cases recommended for core biopsy from May 2018 to May 2021...
May 1, 2024: Translational Oncology
https://read.qxmd.com/read/38696845/identification-of-fty720-and-coh29-as-novel-topoisomerase-i-catalytic-inhibitors-by-experimental-and-computational-studies
#11
JOURNAL ARTICLE
Huang Zeng, Shengyuan Zhang, Hua Nie, Junhao Li, Jiunlong Yang, Yuanbei Zhuang, Yingjie Huang, Miao Zeng
The development of novel topoisomerase I (TOP1) inhibitors is crucial for overcoming the drawbacks and limitations of current TOP1 poisons. Here, we identified two potential TOP1 inhibitors, namely, FTY720 (a sphingosine 1-phosphate antagonist) and COH29 (a ribonucleotide reductase inhibitor), through experimental screening of known active compounds. Biological experiments verified that FTY720 and COH29 were nonintercalative TOP1 catalytic inhibitors that did not induce the formation of DNA-TOP1 covalent complexes...
April 29, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38696844/molecular-docking-approach-for-the-design-and-synthesis-of-new-pyrazolopyrimidine-analogs-of-roscovitine-as-potential-cdk2-inhibitors-endowed-with-pronounced-anticancer-activity
#12
JOURNAL ARTICLE
Ola Alaa Hamed, Nehad Abou-Elmagd El-Sayed, Walaa R Mahmoud, Ghada F Elmasry
Cyclin-dependent kinase 2 (CDK2) is a vital protein for controlling cell cycle progression that is critically associated with various malignancies and its inhibition could offer a convenient therapeutic approach in designing anticancer remedies. Consequently, this study aimed to design and synthesize new CDK2 inhibitors featuring roscovitine as a template model. The purine ring of roscovitine was bioisosterically replaced with the pyrazolo[3,4-d]pyrimidine scaffold, in addition to some modifications in the side chains...
April 30, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38696656/plastic-surgeons-perspective-on-the-fda-breast-implant-regulatory-mandates
#13
JOURNAL ARTICLE
Karie Villanueva, Nisha Gupta, Tahera Alnaseri, Andrew L Da Lio, Jason Roostaeian, Michael DeLong
BACKGROUND: In 2021, the US Food and Drug Administration (FDA) issued a new checklist, labeling and rupture screening recommendations for breast implants to improve the decision-making process. OBJECTIVES: This study aims to understand the plastic surgeon's perspective on these changes and their perceived impact on clinical practice. METHODS: In September 2023, a 27 multiple-choice cross-sectional survey was distributed to 4,352 active members of the American Society of Plastic Surgeons to evaluate attitudes on the FDA's black box warning, informed decision checklist, and updated rupture screening recommendations...
May 2, 2024: Aesthetic Surgery Journal
https://read.qxmd.com/read/38696423/reducing-non-communicable-diseases-among-palestinian-populations-in-gaza-a-participatory-comparative-and-cost-effectiveness-modeling-assessment
#14
JOURNAL ARTICLE
Sanjay Basu, John S Yudkin, Mohammed Jawad, Hala Ghattas, Bassam Abu Hamad, Zeina Jamaluddine, Gloria Safadi, Marie-Elizabeth Ragi, Raeda El Sayed Ahmad, Eszter P Vamos, Christopher Millett
We sought to assess the effectiveness and cost-effectiveness of potential new public health and healthcare NCD risk reduction efforts among Palestinians in Gaza. We created a microsimulation model using: (i) a cross-sectional household survey of NCD risk factors among 4,576 Palestinian adults aged ≥40 years old in Gaza; (ii) a modified Delphi process among local public health experts to identify potentially feasible new interventions; and (iii) reviews of intervention cost and effectiveness, modified to the Gazan and refugee contexts...
2024: PLOS Glob Public Health
https://read.qxmd.com/read/38696229/pna-functionalized-silica-nanowires-filled-glass-microtube-for-ultrasensitive-and-label-free-detection-of-mirna-21
#15
JOURNAL ARTICLE
Shiwei Xu, Guofeng Wang, Yueyue Feng, Juanjuan Zheng, Liying Huang, Jiahao Liu, Yisha Jiang, Yajun Wang, Nannan Liu
MicroRNAs (miRNAs) are endogenous and noncoding single-stranded RNA molecules with a length of approximately 18-25 nucleotides, which play an undeniable role in early cancer screening. Therefore, it is very important to develop an ultrasensitive and highly specific method for detecting miRNAs. Here, we present a bottom-up assembly approach for modifying glass microtubes with silica nanowires (SiNWs) and develop a label-free sensing platform for miRNA-21 detection. The three-dimensional (3D) networks formed by SiNWs make them abundant and highly accessible sites for binding with peptide nucleic acid (PNA)...
May 2, 2024: Analytical Chemistry
https://read.qxmd.com/read/38695983/a-novel-preclinical-model-of-the-normal-human-breast
#16
JOURNAL ARTICLE
Anthony J Wilby, Sara Cabral, Nastaran Zoghi, Sacha J Howell, Gillian Farnie, Hannah Harrison
Improved screening and treatment have decreased breast cancer mortality, although incidence continues to rise. Women at increased risk of breast cancer can be offered risk reducing treatments, such as tamoxifen, but this has not been shown to reduce breast cancer mortality. New, more efficacious, risk-reducing agents are needed. The identification of novel candidates for prevention is hampered by a lack of good preclinical models. Current patient derived in vitro and in vivo models cannot fully recapitulate the complexities of the human tissue, lacking human extracellular matrix, stroma, and immune cells, all of which are known to influence therapy response...
May 2, 2024: Journal of Mammary Gland Biology and Neoplasia
https://read.qxmd.com/read/38693256/radiological-features-of-screening-detected-and-interval-breast-cancers-and-subsequent-survival-in-eastern-finnish-women
#17
JOURNAL ARTICLE
Aki Nykänen, Mazen Sudah, Amro Masarwah, Ritva Vanninen, Hidemi Okuma
Interval breast cancers are diagnosed between scheduled screenings and differ in many respects from screening-detected cancers. Studies comparing the survival of patients with interval and screening-detected cancers have reported differing results. The aim of this study was to investigate the radiological and histopathological features and growth rates of screening-detected and interval breast cancers and subsequent survival. This retrospective study included 942 female patients aged 50-69 years with breast cancers treated and followed-up at Kuopio University Hospital between January 2010 and December 2016...
May 1, 2024: Scientific Reports
https://read.qxmd.com/read/38692648/familiarity-confidence-and-preference-of-artificial-intelligence-feedback-and-prompts-by-australian-breast-cancer-screening-readers
#18
JOURNAL ARTICLE
Phuong Dung Yun Trieu, Melissa L Barron, Zhengqiang Jiang, Seyedamir Tavakoli Taba, Ziba Gandomkar, Sarah J Lewis
ObjectivesThis study explored the familiarity, perceptions and confidence of Australian radiology clinicians involved in reading screening mammograms, regarding artificial intelligence (AI) applications in breast cancer detection.MethodsSixty-five radiologists, breast physicians and radiology trainees participated in an online survey that consisted of 23 multiple choice questions asking about their experience and familiarity with AI products. Furthermore, the survey asked about their confidence in using AI outputs and their preference for AI modes applied in a breast screening context...
May 2, 2024: Australian Health Review: a Publication of the Australian Hospital Association
https://read.qxmd.com/read/38692082/prognostic-value-of-endopredict-test-in-patients-with-hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-primary-breast-cancer-screened-for-the-randomized-double-blind-phase-iii-unirad-trial
#19
JOURNAL ARTICLE
F Penault-Llorca, F Dalenc, S Chabaud, P Cottu, D Allouache, D Cameron, J Grenier, L Venat Bouvet, A Jegannathen, M Campone, M Debled, A-C Hardy-Bessard, S Giacchetti, P Barthelemy, L Kaluzinski, A Mailliez, M-A Mouret-Reynier, E Legouffe, A Cayre, M Martinez, C Delbaldo, D Mollon-Grange, E J Macaskill, M Sephton, L Stefani, B Belgadi, M Winter, H Orfeuvre, M Lacroix-Triki, H Bonnefoi, J Bliss, J-L Canon, J Lemonnier, F Andre, T Bachelot
BACKGROUND: The purpose of this study was to evaluate the prognostic value of the multigene EndoPredict test in prospectively collected data of patients screened for the randomized, double-blind, phase III UNIRAD trial, which evaluated the addition of everolimus to adjuvant endocrine therapy in high-risk, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer. PATIENTS AND METHODS: Patients were classified into low or high risk according to the EPclin score, consisting of a 12-gene molecular score combined with tumor size and nodal status...
April 30, 2024: ESMO Open
https://read.qxmd.com/read/38692045/non-invasive-screening-and-subtyping-for-breast-cancer-by-serum-sers-combined-with-lgb-dnn-algorithms
#20
JOURNAL ARTICLE
Qiyi Zhang, Yuxiang Lin, Duo Lin, Xueliang Lin, Miaomiao Liu, Hong Tao, Jinxun Wu, Tingyin Wang, Chuan Wang, Shangyuan Feng
Early detection of breast cancer and its molecular subtyping is crucial for guiding clinical treatment and improving survival rate. Current diagnostic methods for breast cancer are invasive, time consuming and complicated. In this work, an optical detection method integrating surface-enhanced Raman spectroscopy (SERS) technology with feature selection and deep learning algorithm was developed for identifying serum components and building diagnostic model, with the aim of efficient and accurate noninvasive screening of breast cancer...
April 27, 2024: Talanta
keyword
keyword
7240
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.